Purchase Short-Term Access
Use of Twice-Daily Exenatide in Basal Insulin–Treated Patients With Type 2 Diabetes: A Randomized, Controlled Trial
John B. Buse, MD, PhD; Richard M. Bergenstal, MD; Leonard C. Glass, MD; Cory R. Heilmann, PhD; Michelle S. Lewis, PhD; Anita Y.M. Kwan, MS; Byron J. Hoogwerf, MD; Julio Rosenstock, MD
Annals of Internal Medicine 2011;154:103-112.
doi:10.7326/0003-4819-154-2-201101180-00300
Purchase Online access to this article for 24 hours
